Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
3 High-Yielding Dividend Stocks to Buy on the Dip
02:30pm, Wednesday, 13'th Apr 2022 The Motley Fool
These stocks look like some of the best bargains out there right now.
Here Are 2 Reasons Why Vaccine Stocks Might Cool Off Soon
02:23pm, Wednesday, 13'th Apr 2022 The Motley Fool
Other segments of the biopharma market are likely to steal the limelight.
Glaxo (GSK) to Buy Sierra for $1.9B, Add Hematology Drug
02:18pm, Wednesday, 13'th Apr 2022 Zacks Investment Research
The acquisition of Sierra Oncology (SRRA) will add late-stage oncology pipeline candidate, momelotinib to Glaxo's (GSK) hematology pipeline.
3 Things About Moderna That Smart Investors Know
02:15pm, Wednesday, 13'th Apr 2022 The Motley Fool
It'll need to work hard to maintain its current position, if it's possible at all.
Ocugen (OCGN) Stock Down as FDA Puts Hold on Covaxin Study
01:55pm, Wednesday, 13'th Apr 2022 Zacks Investment Research
Ocugen (OCGN) is conducting the OCU-002 study to support its BLA for the approval of Covaxin in the United States. The FDA places a clinical hold on this study.
2 Unbelievable Clues That Biotech Revenue May Soon Rival Big Pharma
11:00am, Wednesday, 13'th Apr 2022 The Motley Fool
Biotech today makes us think of blockbuster products.
FDA Finds Deficiencies in Myovant (MYOV), Pfizer's Myfembree sNDA
06:47pm, Tuesday, 12'th Apr 2022 Zacks Investment Research
Though the FDA identified deficiencies in Myovant's (MYOV) Myfembree sNDA for managing endometriosis-associated pain, a final decision on the application is yet to be communicated.
Why Myovant Sciences Stock Is Crashing Today
03:49pm, Tuesday, 12'th Apr 2022 The Motley Fool
The FDA has identified deficiencies with Myovant's regulatory filing for Myfembree.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Aeglea Shares Additional Phase 3 Data In Inherited Metabolic Disease
Aeglea BioTherapeutics Inc (NAS
Is Principal U.S. MegaCap ETF (USMC) a Strong ETF Right Now?
10:20am, Tuesday, 12'th Apr 2022 Zacks Investment Research
Smart Beta ETF report for USMC
Is Global X SuperDividend U.S. ETF (DIV) a Strong ETF Right Now?
10:20am, Tuesday, 12'th Apr 2022 Zacks Investment Research
Smart Beta ETF report for DIV
Confusion Reigns: Another Volatile Week
06:03am, Sunday, 10'th Apr 2022 Seeking Alpha
What's Working this week are healthcare, consumer staples, and utilities. What's Not Working this week are transports, semis, and homebuilders.
3 Safe Stocks to Buy in an Uncertain Market
11:31am, Saturday, 09'th Apr 2022 The Motley Fool
Their solid underlying businesses and dividends make these stocks more secure than most.
These COVID Stocks Will Be Incredibly Profitable
11:30am, Saturday, 09'th Apr 2022 The Motley Fool
As COVID-19 becomes endemic, what will the market look like for therapies and vaccines?
3 Pharmaceutical Stocks With Awesome Futures
11:15am, Saturday, 09'th Apr 2022 The Motley Fool
The market is so pessimistic about anything COVID-related that everything has gotten super cheap.
